SCHEMBL29914322

SCHEMBL29914322

CC(=O)Nc1nc(F)c(CN2C[C@@]3(Cc4cc(NC5CC5)ncc4O3)C[C@@H]2C)s1

nearest known ligand 0.41

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ OGA O60502 20/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23304748 1.00 OGA (0.41) OGA
SCHEMBL23304758 0.92 OGA (0.40) OGA
SCHEMBL29914281 0.92 OGA (0.40) OGA
SCHEMBL29914313 0.91 OGA (0.39) OGA
SCHEMBL23305253 0.91 OGA (0.39) OGA
SCHEMBL23304733 0.90 OGA (0.42) OGA
SCHEMBL29914282 0.90 OGA (0.42) OGA
SCHEMBL23305195 0.89 OGA (0.41) OGA
SCHEMBL29914328 0.89 OGA (0.41) OGA
SCHEMBL23304750 0.89 OGA (0.42) OGA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114929709-B Spirocyclic O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranoside inhibitors 比奥根MA公司 2024-08-30 — — CN claimed
EP-4051682-A1 SPIROCYCLIC O-GLYCOPROTEIN-2-ACETAMIDO-2-DEOXY-3-D-GLUCOPYRANOSIDASE INHIBITORS Biogen MA Inc. (US) 2022-09-07 — — EP disclosed
Send feedback